Home / Going-concern warnings / Immuneering Corp

3/5Immuneering Corp (IMRX): Going-concern doubt

Filed 2025-08-13 路 Form 10-Q 路 Accession 0001790340-25-000104 micro

Market data

Price before filing: $3.25 (2025-08-12 close, split/dividend-adjusted)
Market cap at flag: $127.7M (2025-08-13) 路 Latest: $232.3M (2026-10-16)

What happened next

WindowIMRXSPYvs SPY
30 days+161.2%+2.3%+158.9%2025-09-12
90 days+107.4%+6.6%+100.8%2025-11-11
180 days+52.3%+8.6%+43.7%2026-02-09

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: 7 insiders bought $334K (12 purchases)
30 days after: none reported.

DateInsiderTypeSharesPriceValue10b5-1 planSource
2025-06-17Schall Thomas J.
Director
Purchase40,485$2.21$89KnoForm 4
2025-06-18Feinberg Peter
Director
Purchase25,000$2.53$63KnoForm 4
2025-06-18Zeskind Benjamin J.
PRESIDENT AND CEO, Director, 10% owner
Purchase21,000$2.39$50KnoForm 4
2025-06-20Brakewood Harold Eugene
Chief Business Officer
Purchase1,900$2.53$5KnoForm 4
2025-06-20Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Purchase7,415$2.70$20KnoForm 4
2025-06-23Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
Purchase6,007$2.43$15KnoForm 4
2025-06-27Schall Thomas J.
Director
Purchase9,500$3.66$35KnoForm 4
2025-07-01Zeskind Benjamin J.
PRESIDENT AND CEO, Director, 10% owner
Purchase2,985$3.38$10KnoForm 4
2025-07-02HAUSMAN DIANA
Director
Purchase2,500$3.60$9KnoForm 4
2025-07-02HAUSMAN DIANA
Director
Purchase3,000$3.62$11KnoForm 4
2025-07-02Neufeld Leah R
CHIEF PEOPLE OFFICER
Purchase700$3.57$2KnoForm 4
2025-07-02Zeskind Benjamin J.
PRESIDENT AND CEO, Director, 10% owner
Purchase7,015$3.53$25KnoForm 4
2025-08-13: red flag filed

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-15 to 2025-09-12. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"Based on these factors, as of August 13, 2025, the issuance date of the interim condensed consolidated financial statements for the three and six months ended June 30, 2025, the Company has concluded that there is substantial doubt about its ability to continue as a going concern for a period of one year from the date that these interim condensed consolidated financial statements are issued."

Quoted from the filing. Source

What this means

The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.

Source: management disclosure in Form 10-Q (period 2025-06-30)

Why this score: quarterly (unaudited) disclosure

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.